Establishment of NAFLD Cohort and Development of Fibrosis Markers
Recruiting · NCT02206841 · Observational (researchers observe without assigning treatment) · Lead sponsor: Seoul National University Boramae Hospital
View the official record on ClinicalTrials.gov →Interventions studied
ARFILiver biopsySWETransient elastography
What this trial is about
This study is designed for establishment of non-alcoholic fatty liver disease patients cohort to development of markers to predict histologic progression of liver fibrosis.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with histologically confirmed fatty liver disease
- Patients with radiologically confirmed fatty liver disease
Exclusion criteria
- History of significant alcohol consumption
- Viral hepatitis
- Autoimmune hepatitis
- Metabolic diseases (e.g. hemochromatosis, M. Wilson, alpha 1-antitrypsin deficiency)
- Hepatotoxic medication (e.g. amiodarone)
Where it is running
1 location listed.
- Seoul Metropolitan Government Seoul National University - Seoul, South Korea